sv3asr
As filed with the Securities and Exchange Commission on
May 21, 2010
Registration No. 333-
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
Form S-3
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF
1933
ProAssurance
Corporation
(Exact name of registrant as
specified in its charter)
|
|
|
Delaware
|
|
63-1261433
|
(State or Other Jurisdiction
of
Incorporation or Organization)
|
|
(IRS Employer
Identification No.)
|
100 Brookwood Place
Birmingham, Alabama 35209
(205) 877-4400
(Address, Including Zip Code,
and Telephone Number, Including Area Code, of Registrants
Principal Executive Offices)
W. Stancil Starnes
Chairman and Chief Executive Officer
ProAssurance Corporation
100 Brookwood Place
Birmingham, Alabama 35209
(205)
877-4400
(Name, Address, Including Zip
Code, and Telephone Number, Including Area Code, of Agent for
Service)
Approximate date of commencement of proposed sale of the
security to the public: From time to time after
the effective date of this Registration Statement.
If the only securities being registered on this form are being
registered pursuant to dividend or interest reinvestment plans,
please check the following
box. o
If any of the securities being registered on this form are to be
offered on a delayed or continuous basis pursuant to
Rule 415 under the Securities Act of 1933, other than
securities offered only in connection dividend or interest
reinvestment plans, please check the following
box. þ
If this form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
please check the following box and list the Securities Act
registration statement number of the earlier effective
registration statement for the same
offering. o
If this form is a post-effective amendment filed pursuant to
Rule 462(c) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
If this form is a registration statement filed pursuant to
General Instruction I.D. or a post-effective amendment that
shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the
following
box. þ
If this Form is a post-effective amendment to a registration
statement filed pursuant to General Instruction I.D. filed to
register additional securities or additional classes of
securities pursuant to Rule 413(b) under the Securities
Act, check the following
box. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in Rule
12b-2 of the
Exchange Act. (Check one):
|
|
|
|
Large
accelerated
filer þ
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Smaller
reporting
company o
|
(Do not check if a smaller reporting company)
CALCULATION
OF REGISTRATION FEE
|
|
|
|
Title of Each Class of
|
|
|
Amount of Registration
|
Securities to be Registered
|
|
|
Fee
|
Common Stock, Preferred Stock and Debt Securities
|
|
|
(1)
|
|
|
|
|
|
|
(1) |
An indeterminate aggregate initial offering price or number of
the securities of each identified class is being registered as
may from time to time be offered at indeterminate prices. In
accordance with Rules 456(b) and 457(r), the Registrant is
deferring payment of all registration fees that may be payable.
|
PROSPECTUS
ProAssurance
Corporation
Common Stock
Preferred Stock
Debt Securities
We may offer and sell, from time to time:
|
|
|
|
|
shares of our common stock;
|
|
|
|
shares of our preferred stock; and
|
|
|
|
our debt securities
|
We may not use this prospectus to sell securities unless
accompanied by a prospectus supplement or a prospectus contained
in a post-effective amendment to the registration statement of
which this prospectus is a part.
This prospectus describes general terms that may apply to these
securities. When we decide to sell a particular class or series
of those securities, we will provide the specific terms of the
securities in one or more supplements to this prospectus, one or
more post-effective amendments to the registration statement of
which this prospectus forms a part or in documents incorporated
into this prospectus by reference. The terms of the securities
will include the initial offering price, the aggregate amount of
the offering, listing on any securities exchange or quotation
system, investment considerations, and the underwriters, dealers
and agents, if any, involved in the sale of the securities. We
urge you to read carefully this prospectus, any prospectus
supplement, and any documents incorporated by reference into
this prospectus carefully before you invest.
Shares of our common stock are listed on the New York Stock
Exchange under the symbol PRA.
Investing in our securities involves risk. You should
consider the Risk Factors described on page 2
herein and, if applicable, in risk factors described in any
accompanying prospectus supplement, any prospectus contained in
a post-effective amendment to the registration statement and in
the documents that are incorporated by reference into this
prospectus.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed on the adequacy or accuracy of this
prospectus. Any representation to the contrary is a criminal
offense.
The date of this prospectus is
[ ],
2010.
ABOUT
THIS PROSPECTUS
References in this prospectus to ProAssurance,
we, us and our refer to
ProAssurance Corporation, an insurance holding company
incorporated in Delaware, and its subsidiaries, unless the
context otherwise requires.
This prospectus is part of a registration statement that we
filed with the Securities and Exchange Commission
(SEC) using an automatic shelf
registration process for well known seasoned issuers
In accordance with General Instruction I.D. of
Form S-3.
Under the automatic shelf process, we may sell from time to time
the common stock, preferred stock or debt securities described
in this prospectus in one or more offerings. This prospectus
provides you with a general description of the securities we may
offer. Each time we use this prospectus to offer securities, we
will provide a prospectus supplement or a prospectus contained
in a post-effective amendment to the registration statement of
which this prospectus is a part that will contain or indicate
where the specific information about the terms of the offering
may be obtained. The prospectus supplement, the prospectus
contained in a post-effective amendment or the documents
incorporated by reference into this prospectus may also add,
update or change information contained in this prospectus and to
the extent such information differs in any way from information
set forth in this prospectus, you should rely on information set
forth in the prospectus supplement, the prospectus contained in
a post-effective amendment or the documents incorporated by
reference into this prospectus. You should read carefully this
prospectus, any prospectus supplement, the prospectus contained
in a post-effective amendment or the documents we incorporate by
reference, together with additional information described below
under Information Incorporated By Reference.
You should read both this prospectus and any prospectus
supplement together with the additional information described
below under Where You Can Find More Information. You
should rely only on the information contained or incorporated by
reference in this prospectus or a prospectus supplement, the
prospectus contained in a post-effective amendment. We have not
authorized any other person to provide you with different
information. If anyone provides you with different or
inconsistent information, you should not rely on it. We are not
making an offer to sell these securities in any jurisdiction
where the offer or sale is not permitted. You should assume that
the information appearing in this prospectus or any prospectus
supplement, or any prospectus contained in a post-effective
amendment, as well as information we file with the SEC and
incorporated by reference, is accurate only as of the date on
the front cover of the applicable document. Our business,
financial condition, results of operations and prospects may
have changed since those dates.
RISK
FACTORS
Investing in our securities involves risk. Please see the risk
factors described in our most recent Annual Report on
Form 10-K,
which are incorporated by reference into this prospectus. Before
making an investment decision, you should carefully consider
such risks as well as updates to such risk factors, if any,
included in our subsequent Quarterly Reports on
Form 10-Q
and the other information we incorporate by reference into this
prospectus. Additional risk factors may be included in a
prospectus supplement relating to an offering of a particular
class or series of securities or in a prospectus contained in a
post-effective amendment relating to such an offering.
SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS
Statements made in this prospectus, any prospectus supplement
and the documents incorporated by reference herein or therein
concerning our future results and performance and other matters
not directly related to historical information are
forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 (Securities
Act) and Section 21E of the Securities Exchange Act
of 1934 (the Exchange Act). The words
anticipates, believes,
estimates, expects, hopes,
hopeful, plans, intends,
may, should, will and
similar expressions are intended, but are not the exclusive
means, to identify these forward-looking statements. These
forward-looking statements include among other things statements
concerning: liquidity and capital requirements, investment
valuation and performance, return on equity, financial
2
ratios, net income, premiums, losses and loss reserves, premium
rates and retention of current business, competition and market
conditions, the expansion of product lines, the development or
acquisition of business, the availability of acceptable
reinsurance, actions by regulators and rating agencies, court
actions, legislative actions, payment or performance of
obligations under debt or other contractual obligations, payment
of dividends, and other matters.
These forward-looking statements are based upon our estimates
and anticipation of future events that are subject to certain
risks and uncertainties that could cause actual results to vary
materially from historical or expected results described in the
forward-looking statements. These risks and uncertainties
include, but are not limited to those referenced under the
heading Risk Factors in this prospectus. Due to such
risks and uncertainties, you are urged not to place undue
reliance on forward-looking statements. Additional factors that
could cause actual results to differ from those predicted will
be discussed in our reports on
Forms 10-K,
10-Q and
8-K
incorporated by reference herein and in prospectus supplements
and other offering materials.
All forward-looking statements included in this document are
based upon information available to us on the date hereof, and
we undertake no obligation, other than as may be required under
the federal securities laws, to publicly update or revise any
forward-looking statements, whether as a result of new
information, future events or otherwise.
PROASSURANCE
CORPORATION
We are a holding company for property and casualty insurance
companies and our operating results are primarily derived from
the operations of our insurance subsidiaries, which principally
write medical and other professional liability insurance.
Our mission is to be the preferred source of professional
liability protection by providing unparalleled claims defense,
highly responsive customer service and innovative risk
management while maintaining our commitment to long-term
financial strength. We emphasize our pledge that each insured
professional will be treated fairly in all of our conduct with
them and that all of our business actions will be informed by
the core values that guide our organization: integrity, respect,
collaboration, communication and enthusiasm. We believe our
customer focus and continued doctor involvement in managing our
medical risks combined with our financial strength, strong
reputation and proven ability to manage claims, will enable us,
over the long-term, to profitably expand our operations. We have
successfully acquired and integrated companies and books of
business in the past and believe our financial size and strength
make us an attractive acquirer. We emphasize disciplined
underwriting and do not manage our business to achieve a certain
level of premium growth or market share. In addition to prudent
risk selection and pricing, we seek to control our underwriting
results through effective claims management, and have fostered a
strong culture of defending claims that we believe have no
merit. We manage claims by tailoring claims handling to the
legal climate of each state, which we believe differentiates us
from other national writers.
We have sustained our financial stability during difficult
market conditions through responsible pricing and loss reserving
practices and through conservative investment practices. We are
committed to maintaining prudent operating and financial
leverage and conservatively investing our assets. Our overall
investment strategy is to focus on maximizing current income
from our investment portfolio while maintaining safety,
liquidity, moderate duration and portfolio diversification. We
recognize the importance that our customers and producers place
on the financial strength of our principal insurance
subsidiaries and we manage our business to protect our financial
security.
Our executive offices are located at 100 Brookwood Place,
Birmingham, Alabama 35209, and our telephone number is
(205) 877-4400.
3
USE OF
PROCEEDS
Unless otherwise indicated in a prospectus supplement, we expect
to use the net proceeds from the sale of the offered securities
for general corporate purposes, which may include, without
limitation, the following purposes:
|
|
|
|
|
contribute capital to insurance subsidiaries;
|
|
|
|
provide working capital;
|
|
|
|
make acquisitions;
|
|
|
|
purchase equity or fixed income investments;
|
|
|
|
repay or refinance debt or other corporate obligations; or
|
|
|
|
repurchase and redeem outstanding securities.
|
Pending any specific application, we may initially invest funds
in interest-bearing short term or investment grade securities.
DESCRIPTION
OF CAPITAL STOCK
Our certificate of incorporation authorizes the issuance of up
to 100,000,000 shares of common stock, par value $0.01 per
share, and 50,000,000 shares of preferred stock, par value
$0.01 per share, the rights and preferences of which may be
established from time to time by our board of directors. As of
March 26, 2010, there were issued and outstanding
34,340,312 shares of our common stock, of which we held
1,811,356 shares as treasury shares, and no shares of our
preferred stock.
The following is a summary description of our capital stock.
Common
Stock
Holders of record of common stock are entitled to one vote per
share on all matters upon which stockholders have the right to
vote. The rights attached to the shares of common stock do not
provide for cumulative voting rights or preemptive rights.
Therefore, holders of more than 50% of the shares of common
stock are able to elect all our directors eligible for election
each year. All issued and outstanding shares of our common stock
are validly issued, fully paid and non-assessable. Holders of
our common stock are entitled to such dividends as may be
declared from time to time by our board of directors out of
funds legally available for that purpose. Upon dissolution,
holders of our common stock are entitled to share pro rata in
the assets of our company remaining after payment in full of all
of our liabilities and obligations, including payment of the
liquidation preference, if any, of any preferred stock then
outstanding. There are no redemption or sinking fund provisions
applicable to the common stock.
Preferred
Stock
Our board of directors may, from time to time, issue up to an
aggregate 50,000,000 shares of preferred stock in one or
more series without stockholder approval. The board of directors
can fix the designation powers, rights, preferences and
privileges of the shares of each series and any qualifications,
limitations or restrictions, including, but not limited to:
|
|
|
|
|
dividend rights and preferences over dividends on our common
stock;
|
|
|
|
conversion rights or exchange rights, if any;
|
|
|
|
voting rights, if any (in addition to those provided by law);
|
|
|
|
redemption rights, if any, and any sinking fund provision made
for that purpose; and
|
|
|
|
rights on liquidation, including preferences over the common
stock.
|
4
Issuance of preferred stock, while providing desirable
flexibility in connection with possible acquisitions and other
corporate purposes, could have the effect of making it more
difficult for a third party to acquire, or of discouraging a
third party from attempting to acquire, a majority of our
outstanding voting stock. No shares of preferred stock are
currently outstanding. We have no present plans to issue any
shares of preferred stock.
The authorization of undesignated preferred stock in our charter
makes it possible for our board of directors to issue preferred
stock with voting or other rights or preferences that could
impede the success of any attempt to change control of us. This
authorization may have the effect of deterring hostile takeovers
or delaying changes in control or management of us.
Delaware
Anti-Takeover Statute
Under Delaware law, we may not engage in a business
combination, which includes a merger or sale of more than
10% of our assets, with any interested stockholder,
namely, a stockholder who owns 15% or more of our outstanding
voting stock, as well as affiliates and associates of any of
these persons, for three years following the time that
stockholder became an interested stockholder unless:
|
|
|
|
|
the transaction in which the stockholder became an interested
stockholder is approved by our board of directors prior to the
time the interested stockholder attained that status;
|
|
|
|
upon completion of the transaction that resulted in the
stockholder becoming an interested stockholder, the interested
stockholder owned at least 85% of our voting stock outstanding
at the time the transaction commenced, excluding those shares
owned by persons who are directors and also officers; or
|
|
|
|
at or after the time the stockholder became an interested
stockholder the business combination is approved by the board of
directors and authorized at an annual or special meeting of
stockholders by the affirmative vote of at least two-thirds of
the outstanding voting stock which is not owned by the
interested stockholder.
|
Limitations
on Liability and Indemnification of Officers and
Directors
Our certificate of incorporation limits the liability of
directors to the fullest extent permitted by Delaware law. In
addition, the certificates of incorporation and bylaws of our
companies provide that we will indemnify our directors and
officers to the fullest extent permitted by Delaware law. We
believe that the provisions in our certificate of incorporation
and bylaws are necessary to attract and retain qualified persons
as directors and officers.
Insurance
Regulations Concerning Change of Control
State insurance laws intended primarily for the protection of
policyholders contain certain requirements that must be met
prior to any change of control of an insurance company or
insurance holding company that is domiciled, or in some cases,
having such substantial business that it is deemed commercially
domiciled, in that state. These requirements may include the
advance filing of specific information with the state insurance
commission, a public hearing on the matter, and review and
approval of the change of control by the state agencies. We have
property and casualty insurance subsidiaries domiciled in
Alabama, Michigan, District of Columbia, Wisconsin and Illinois.
Under the insurance laws in these states, control is
presumed to exist through the ownership of 10% of more of the
voting securities of an insurance company or any company that
controls the insurance company, except in Alabama the percentage
of ownership is 5% of the voting securities. Any purchase of our
shares that would result in the purchaser owning more than the
threshold percentage of our voting securities will be presumed
to result in the acquisition of control of our insurance
subsidiaries and require prior regulatory approval.
5
DESCRIPTION
OF DEBT SECURITIES
We may issue debt securities from time to time in one or more
series. This section summarizes the general terms and provisions
of the debt securities that are common to all series. The
specific terms relating to any series of our debt securities
that we offer will be described in a prospectus supplement or in
a prospectus contained in a post-effective amendment, or
documents that are incorporated by reference into this
prospectus. In addition, the prospectus supplement will show a
ratio of earnings to fixed charges in accordance with SEC
requirements.
The debt securities will be governed by a document called an
indenture in accordance with the requirements of the
Trust Indenture Act of 1939. An indenture is a contract
between a financial institution, acting on your behalf as
trustee of the debt securities offered, and us. The debt
securities will be issued pursuant to one or more indentures.
When we refer to the applicable indenture or
indenture in this prospectus, we are referring to
the indenture under which your debt securities are issued, as
supplemented by any supplemental indenture applicable to your
debt securities. The trustee has two main roles. First, subject
to some limitations on the extent to which the trustee can act
on your behalf, the trustee can enforce your rights against us
if we default on our obligations under the applicable indenture.
Second, the trustee performs certain administrative duties for
us.
We have entered into an indenture with Wilmington
Trust Company as trustee. We have summarized certain terms
and provisions of this indenture herein. This summary is not
complete. If we refer to particular provisions of the indenture,
the provisions, including definitions of certain terms, are
incorporated by reference as part of this summary. The indenture
is filed as an exhibit to the registration statement of which
this prospectus is a part and is incorporated by reference. The
particular terms of the offered debt securities and the extent
to which the indenture and the general provisions described
below may apply to the offered debt securities will be described
in a prospectus supplement .
We may issue the debt securities as original issue discount
securities, which are securities that are offered and sold at a
substantial discount to their stated principal amount. The
prospectus supplement relating to original issue discount
securities will describe federal income tax consequences and
other special considerations applicable to them. The debt
securities may also be issued as indexed securities as described
in more detail in the prospectus supplement relating to any of
the particular debt securities. The prospectus supplement
relating to specific debt securities will also describe any
special considerations and any material additional tax
considerations applicable to such debt securities.
General
The indenture will not limit the amount of debt securities that
we may issue. We may issue debt securities up to an aggregate
principal amount as we may authorize from time to time. Unless
otherwise indicated in the prospectus supplement, our debt
securities will be unsecured obligations and will rank equally
in right of payment with all of our other unsecured and
unsubordinated indebtedness.
We are a holding company and will primarily depend on the
receipt of dividends from our insurance company subsidiaries to
meet our obligations under the debt securities and our other
outstanding obligations. Because the creditors of our
subsidiaries, and our insurance subsidiaries
policyholders, generally would have a right to receive payment
which is superior to our right to receive payment from the
assets of our subsidiaries, the holders of our debt securities
will effectively be subordinated to the creditors of our
subsidiaries. If we were to liquidate or reorganize, your right
to participate in any distribution of our subsidiaries
assets is necessarily subject to the claims of the
subsidiaries creditors, including their policyholders, and
may also be subject to approval by certain insurance regulatory
authorities having jurisdiction over such subsidiaries.
You should read the applicable prospectus supplement for the
terms of the series of debt securities offered. The terms of the
debt securities described in such prospectus supplement will be
set forth in the
6
applicable indenture and may include the following, as
applicable to the series of debt securities offered thereby:
|
|
|
|
|
the title of the debt securities;
|
|
|
|
the aggregate principal amount of the debt securities and
whether there is any limit on such aggregate principal amount;
|
|
|
|
whether we may reopen the series of debt securities for
issuances of additional debt securities of such series;
|
|
|
|
the date or dates, or how the date or dates will be determined,
when the principal amount of the debt securities will be payable;
|
|
|
|
the amount payable upon acceleration of the maturity of the debt
securities or how this amount will be determined;
|
|
|
|
the interest rate or rates, which may be fixed or variable, that
the debt securities will bear, if any, or how such interest rate
or rates will be determined;
|
|
|
|
the basis upon which interest will be calculated if other than
that of a
360-day year
of twelve
30-day
months;
|
|
|
|
the date or dates from which any interest will accrue or how
such date or dates will be determined;
|
|
|
|
the interest payment dates and the record dates for these
interest payments;
|
|
|
|
whether the debt securities are redeemable at our option;
|
|
|
|
whether there are any sinking fund or other provisions that
would obligate us to purchase or otherwise redeem the debt
securities;
|
|
|
|
the date, if any, after which and the price or prices at which
the series of debt securities may, in accordance with any
optional or mandatory redemption provisions, be redeemed and the
other detailed terms and provisions of those optional or
mandatory redemption provisions, if any;
|
|
|
|
if the debt securities may be converted into or exercised or
exchanged for our common stock or preferred stock or any other
of our securities or any securities of any other person, the
terms on which conversion, exercise or exchange may occur,
including whether conversion, exercise or exchange is mandatory,
at the option of the holder or at our option or at the option of
any other person, the date on or the period during which
conversion, exercise or exchange may occur, the initial
conversion, exercise or exchange price or rate and the
circumstances or manner in which the amount of common stock or
preferred stock or other securities issuable upon conversion,
exercise or exchange may be adjusted;
|
|
|
|
whether the debt securities are subject to mandatory or optional
remarketing or other mandatory or optional resale provisions,
and, if applicable, the date or period during which such resale
may occur, any conditions to such resale and any right of a
holder to substitute securities for the securities subject to
resale;
|
|
|
|
whether the debt securities are subject to repayment at your
option, and if applicable, the conditions to your exercise of
the right to repayment;
|
|
|
|
the form in which we will issue the debt securities, if other
than in registered book-entry only form represented by global
securities, and whether we will have the option of issuing debt
securities in certificated form;
|
|
|
|
whether the amount of payments of principal, premium or
interest, if any, on the debt securities will be determined with
reference to an index, formula or other method (which could be
based on one or more currencies, commodities, equity indices or
other indices) and how these amounts will be determined;
|
|
|
|
the place or places for payment, transfer, conversion
and/or
exchange of the debt securities;
|
7
|
|
|
|
|
the denominations in which the debt securities will be issued;
|
|
|
|
the applicability of the provisions of the applicable indenture
described under defeasance and any provisions in
modification of, in addition to or in lieu of any of these
provisions;
|
|
|
|
material federal income tax considerations that are specific to
the series of debt securities offered;
|
|
|
|
any provisions granting special rights to the holders of the
debt securities upon the occurrence of specified events;
|
|
|
|
whether the applicable indenture contains any changes or
additions to the events of default or covenants described in
this prospectus; and
|
|
|
|
any other terms specific to the series of debt securities
offered.
|
Unless we indicate differently in the applicable prospectus
supplement, the indentures pursuant to which the debt securities
are issued will not contain any provisions that give you
protection in the event we issue additional debt, or in the
event that we are acquired by another entity.
Redemption
If the debt securities are redeemable, the applicable prospectus
supplement will set forth the terms and conditions for such
redemption, including:
|
|
|
|
|
the redemption prices (or method of calculating the same);
|
|
|
|
the redemption period (or method of determining the same);
|
|
|
|
whether such debt securities are redeemable in whole or in part
at our option; and
|
|
|
|
any other provisions affecting the redemption of such debt
securities.
|
Conversion
and Exchange
If any series of the debt securities offered are convertible
into or exchangeable for shares of our common stock or other
securities, the applicable prospectus supplement will set forth
the terms and conditions for such conversion or exchange,
including:
|
|
|
|
|
the conversion price or exchange ratio (or the method of
calculating the same);
|
|
|
|
the conversion or exchange period (or the method of determining
the same);
|
|
|
|
whether conversion or exchange will be mandatory, or at our
option or at the option of the holder;
|
|
|
|
the events requiring an adjustment of the conversion price or
the exchange ratio; and
|
|
|
|
any other provisions affecting conversion or exchange of such
debt securities.
|
Form and
Denomination of Debt Securities
We will issue the debt securities in registered form, either in
book-entry form only or in certificated form, and
unless indicated differently in the applicable prospectus
supplement, the debt securities will be denominated in
U.S. dollars, in minimum denominations of $1,000 and
amounts that are of $1,000 thereafter. We will issue registered
debt securities in book-entry form only, unless we specify
otherwise in the applicable prospectus supplement. Debt
securities issued in book-entry form will be represented by
global securities.
A global security represents one or any other number of
individual debt securities. Generally, all debt securities
represented by the same global securities will have the same
terms. Each debt security issued in book-entry form will be
represented by a global security that we deposit with and
register in the name of a financial institution or its nominee
that we select. The financial institution that we select for
this purpose is called the depositary. Unless we specify
otherwise in the applicable prospectus supplement, The
Depository Trust Company, New York, New York, known as DTC,
will be the depositary for all debt securities that we
8
issue in book-entry form. The depositary or its nominee will
hold such global securities on behalf of financial institutions
that participate in such depositarys book-entry system.
These participating financial institutions, in turn, hold
beneficial interests in the global securities either on their
own behalf or on behalf of their customers.
A global security may not be transferred to or registered in the
name of anyone other than the depositary or its nominee, unless
special termination situations arise. The applicable prospectus
supplement may list situations for terminating a global security
that would apply to the particular series of debt securities.
The depositary, or its nominee, will be the sole legal holder of
all debt securities represented by a global security, and
investors will be permitted to own only beneficial interests in
a global security. Beneficial interests must be held by means of
an account with a broker, bank or other financial institution
that in turn has an account either with the depositary or with
another institution that has an account with the depositary.
Thus, an investor whose security is represented by a global
security will not be a legal holder of the debt security, but an
indirect holder of a beneficial interest in the global security.
In the event that we issue debt securities in certificated form,
or in the event that a global security is terminated, investors
may choose to hold their debt securities either in their own
names or in street name. Debt securities held in
street name are registered in the name of a bank, broker or
other financial institution chosen by the investor, and the
investor would hold a beneficial interest in those debt
securities through the account that he or she maintains at such
bank, broker or other financial institution.
Under the indenture, only the person in whose name a debt
security is registered is recognized as the holder of that debt
security. Consequently, for debt securities issued in global
form, we will recognize only the depositary or its nominee as
the holder of the debt securities, and we will make all payments
on the debt securities to the depositary or its nominee. For
debt securities held in street name, we will recognize only the
intermediary banks, brokers and other financial institutions in
whose names the debt securities are registered as the holders of
those debt securities, and we will make all payments on those
debt securities to them. Investors who hold debt securities in
book entry form or in street name will be indirect holders, and
not holders, of the debt securities.
Our obligations, as well as the obligations of the trustee and
those of any third parties employed by the trustee or us, run
only to the legal holders of the debt securities. We do not have
obligations to investors who hold beneficial interests in global
securities, in street name or by any other indirect means and
who are, therefore, not the legal holders of the debt
securities. This will be the case whether an investor chooses to
be an indirect holder of a debt security, or has no choice in
the matter because we are issuing the debt securities only in
global form.
For example, once we make a payment or give a notice to the
legal holder of the debt securities, we have no further
responsibility with respect to such payment or notice even if
that legal holder is required, under agreements with depositary
participants or customers or by law, to pass it along to the
indirect holders but does not do so. Similarly, if we want to
obtain the approval of the holders for any purpose (for example,
to amend the indenture or to relieve us of the consequences of a
default or of our obligation to comply with a particular
provision of the indenture), we would seek the approval only
from the legal holders, and not the indirect holders, of the
debt securities. Whether and how the legal holders contact the
indirect holders is up to the legal holders.
Notwithstanding the above, when we refer to you or
your in this prospectus, we are referring to
investors who invest in the debt securities being offered by
this prospectus, whether they are the legal holders or only
indirect holders of the debt securities offered. When we refer
to your debt securities in this prospectus, we mean
the series of debt securities in which you hold a direct or
indirect interest.
If you hold debt securities through a bank, broker or other
financial institution, either in book-entry form or in street
name, we encourage you to check with that institution to find
out:
|
|
|
|
|
how it handles securities payments and notices;
|
|
|
|
whether it imposes fees or charges;
|
9
|
|
|
|
|
how it would handle a request for its consent, as a legal holder
of the debt securities, if ever required;
|
|
|
|
if permitted for a particular series of debt securities, whether
and how you can instruct it to send you debt securities
registered in your own name so you can be a legal holder of such
debt securities;
|
|
|
|
how it would exercise rights under the debt securities if there
were a default or other event triggering the need for holders to
act to protect their interests; and
|
|
|
|
if the debt securities are in book-entry form, how the
depositarys rules and procedures will affect these matters.
|
The applicable prospectus supplement for a particular series of
debt securities may list situations for terminating a global
security that would apply only to such series of debt
securities. If a global security were terminated, only the
depositary, and not us or the trustee, would be responsible for
deciding the names of the institutions in whose names the debt
securities represented by the global security would be
registered and, therefore, who would be the legal holders of
those debt securities.
If we cease to issue registered debt securities in global form,
we will issue them:
|
|
|
|
|
only in fully registered certificated form; and
|
|
|
|
unless we indicate otherwise in the applicable prospectus
supplement, in denominations of $1,000 and amounts that are
multiples of $1,000 thereafter.
|
Holders may exchange their certificated securities for debt
securities of smaller denominations or combined into fewer debt
securities of larger denominations, as long as the total
principal amount is not changed.
Holders may exchange or transfer their certificated securities
at the trustees office. We have appointed the trustee to
act as our agent for registering debt securities in the names of
holders transferring debt securities. We may appoint another
entity to perform these functions or perform them ourselves.
Holders will not be required to pay a service charge to transfer
or exchange their certificated securities, but they may be
required to pay any tax or other governmental charge associated
with the transfer or exchange. The transfer or exchange will be
made only if our transfer agent is satisfied with the
holders proof of legal ownership.
If we have designated additional transfer agents for your debt
security, they will be named in your prospectus supplement. We
may appoint additional transfer agents or cancel the appointment
of any particular transfer agent. We may also approve a change
in the location of the office through which any transfer agent
acts.
If any certificated securities of a particular series are
redeemable and we redeem less than all the debt securities of
that series, we may block the transfer or exchange of those debt
securities during the period beginning 15 days before the
day we mail the notice of redemption and ending on the day of
that mailing, in order to freeze the list of holders to prepare
the mailing. We may also refuse to register transfers or
exchanges of any certificated securities selected for
redemption, except that we will continue to permit transfers and
exchanges of the unredeemed portion of any debt security that
will be partially redeemed.
If a registered debt security is issued in global form, only the
depositary will be entitled to transfer and exchange the debt
security as described in this subsection because it will be the
sole holder of the debt security.
Payment
and Paying Agents
On each due date for interest payments on the debt securities,
we will pay interest to each person shown on the trustees
records as owner of the debt securities at the close of business
on a designated day that is in advance of the due date for
interest. We will pay interest to each such person even if such
person no longer owns the debt security on the interest due
date. The designated day on which we will determine the owner of
10
the debt security, as shown on the trustees records, is
also known as the record date. The record date will
usually be fifteen days in advance of the interest due date.
Because we will pay interest on the debt securities to the
holders of the debt securities based on ownership as of the
applicable record date with respect to any given interest
period, and not to the holders of the debt securities on the
interest due date (that is, the day that the interest is to be
paid), it is up to the holders who are buying and selling the
debt securities to work out between themselves the appropriate
purchase price for the debt securities. It is common for
purchase prices of debt securities to be adjusted so as to
prorate the interest on the debt securities fairly between the
buyer and the seller based on their respective ownership periods
within the applicable interest period.
We will make payments on a global security directly to the
depositary, or its nominee, and not to any indirect holders who
own beneficial interests in the global security. An indirect
holders right to those payments will be governed by the
rules and practices of the depositary and its participants, as
described under Form and Denomination of Securities
above.
We will make interest payments on debt securities held in
certificated form by mailing a check on each due date for
interest payments to the holder of the certificated securities,
as shown on the trustees records, as of the close of
business on the record date. We will make all payments of
principal and premium, if any, on the certificated securities by
check at the office of the trustee specified in the applicable
prospectus supplement or in a notice to holders, against
surrender of the certificated security. All payments by check
will be made in
next-day
funds (that is, funds that become available on the day after the
check is cashed).
If payment on a debt security is due on a day that is not a
business day, we will make such payment on the next succeeding
business day. The indenture will provide that such payments will
be treated as if they were made on the original due date for
payment. A postponement of this kind will not result in a
default under any debt security or indenture, and no interest
will accrue on the amount of any payment that is postponed in
this manner.
Book-entry and other indirect holders should consult their
banks or brokers for information on how they will receive
payments on their debt securities.
Events of
Default
You will have special rights if an Event of Default occurs with
respect to your debt securities and such Event of Default is not
cured, as described later in this subsection.
Unless otherwise specified in the applicable prospectus
supplement, the term Event of Default with respect
to the debt securities offered means any of the following:
|
|
|
|
|
We do not pay the principal of, or any premium on, the debt
security on its due date.
|
|
|
|
We do not pay interest on the debt security within 5 days
of its due date.
|
|
|
|
We do not deposit any sinking fund payment, if applicable, with
respect to the debt securities on its due date.
|
|
|
|
We remain in breach of a covenant with respect to the debt
securities for 60 days after we receive a written notice of
default stating that we are in breach. The notice must be sent
by either the trustee or holders of at least 25% of the
principal amount of the debt securities of the affected series.
|
|
|
|
We file for bankruptcy or certain other events of bankruptcy,
insolvency or reorganization occur.
|
|
|
|
Any other Event of Default that may be described in the
applicable prospectus supplement, and set forth in the
applicable indenture, occurs.
|
An Event of Default for a particular series of debt securities
does not necessarily constitute an Event of Default for any
other series of debt securities issued under the same or any
other indenture.
11
If an Event of Default, other than an event of default resulting
from bankruptcy, insolvency or reorganization, has occurred and
has not been cured within the applicable time period, the
trustee or the holders of not less than 25% in principal amount
of the debt securities of the affected series may declare the
entire principal amount of all the debt securities of that
series to be immediately due and payable. This is called a
declaration of acceleration of maturity. A declaration of
acceleration of maturity may be rescinded by the holders of at
least a majority in principal amount of the debt securities of
the affected series if all past due amounts are paid to the
trustee and all other events of default are cured or waived.
In the case of an event of default resulting from certain events
of bankruptcy, insolvency or reorganization, all unpaid
principal of and accrued interest on all debt securities of such
series then outstanding shall be due and payable immediately
without any declaration or other act on the part of the trustee
for such series or the holders of any debt securities of such
series.
The trustee is required to provide the holders notice of an
Event of Default within 90 days after its occurrence
(60 days in the case of an event of bankruptcy). The
trustee may withhold notice to the holders of debt securities of
any default, except in the payment of principal (or premium, if
any) or interest or in the payment of any sinking of purchase
fund installment, if it considers the withholding of notice to
be in the best interests of the holders. Additionally, subject
to the provisions of the applicable indenture relating to the
duties of the trustee, the trustee is not required to take any
action under the applicable indenture at the request of any of
the holders of the debt securities unless such holders offer the
trustee reasonable protection from costs, expenses and liability
(called an indemnity). If reasonable indemnity is
provided pursuant to the applicable indenture, the holders of a
majority in principal amount of the outstanding debt securities
of the relevant series may direct the time, method and place of
conduct of any lawsuit or other formal legal action seeking any
remedy available to the trustee. The trustee may refuse to
follow those directions in certain circumstances. No delay or
omission in exercising any right or remedy will be treated as a
waiver of that right, remedy or Event of Default.
Before you are allowed to bypass your trustee and bring your own
lawsuit or other formal legal action or take other steps to
enforce your rights or protect your interests relating to your
debt securities, the following must occur:
|
|
|
|
|
You must give your trustee written notice that an Event of
Default has occurred and remains uncured.
|
|
|
|
The holders of not less than 25% in principal amount of all
outstanding debt securities of the relevant series must make a
written request that the trustee take action because of the
Event of Default that has occurred and must offer reasonable
indemnity to the trustee against the cost and other liabilities
of taking that action.
|
|
|
|
The trustee must not have taken any action for 60 days
after receipt of the above notice, request and offer of
indemnity.
|
|
|
|
The holders of a majority in principal amount of the debt
securities of the relevant series must not have given the
trustee a direction inconsistent with the above notice or
request.
|
Notwithstanding the above, you are entitled at any time to bring
a lawsuit for the payment of money due on your debt securities
on or after the due date for payment.
Holders of a majority in principal amount of the debt securities
of the affected series may waive any past defaults other than:
|
|
|
|
|
the payment of principal, or any premium or interest, on the
affected series of debt securities; or
|
|
|
|
a default in respect of a covenant that cannot be modified or
amended without the consent of each holder of the affected
series of debt securities.
|
Book-entry and other indirect holders should consult their
banks or brokers for information on how to give notice or
direction to or make a request of the trustee, including any
request of the trustee to take action in connection with a
default with respect to their debt securities.
12
With respect to each series of debt securities, we will furnish
to each trustee, each year, a written statement of certain of
our officers certifying that, to their knowledge, we are in
compliance with the provisions of the indenture applicable to
such series of debt securities, or specifying an Event of
Default.
Merger or
Consolidation
Unless otherwise specified in the applicable prospectus
supplement, the terms of the indentures will generally permit us
to consolidate or merge with another entity. We will also be
permitted to sell all or substantially all of our assets to
another entity. However, we may not take any of these actions
unless, among other things, the following conditions are met:
|
|
|
|
|
in the event that we merge out of existence or sell all or
substantially all of our assets, the resulting entity must agree
to be legally responsible for the debt securities;
|
|
|
|
the merger or sale of all or substantially all of our assets
must not cause a default on the debt securities, and we must not
already be in default (unless the merger or sale would cure the
default) with respect to the debt securities; and
|
|
|
|
we must satisfy any other requirements specified in the
applicable prospectus supplement relating to a particular series
of debt securities.
|
Modification
or Waiver
There are three types of changes we can make to any indenture
and the debt securities issued thereunder.
Changes Requiring Your Approval. There are
changes that we cannot make to the terms or provisions of your
debt securities without your specific approval. Subject to the
provisions of the applicable indenture, without your specific
approval, we may not:
|
|
|
|
|
change the stated maturity of the principal of (or premium, if
any, on), or interest on, your debt securities;
|
|
|
|
change any obligation to pay any additional amounts on your debt
securities;
|
|
|
|
reduce the principal amount of, or premium, if any, or interest
on, or any other amounts due on your debt securities;
|
|
|
|
reduce the amount of principal payable upon acceleration of
maturity of your debt securities;
|
|
|
|
make any change that adversely affects your right to receive
payment on, to convert, to exchange or to require us to
purchase, as applicable, your debt security in accordance with
the terms of the applicable indenture;
|
|
|
|
change the place or currency of payment on your debt securities;
|
|
|
|
impair your right to sue for payment on your debt securities;
|
|
|
|
reduce the percentage of holders of outstanding debt securities
of your series whose consent is needed to modify or amend the
applicable indenture;
|
|
|
|
reduce the percentage of holders of outstanding debt securities
of your series whose consent is needed to waive compliance with
certain provisions of the applicable indenture or to waive
certain defaults of the applicable indenture; or
|
|
|
|
modify any other aspect of the provisions of the applicable
indenture dealing with modification and waiver of past defaults,
changes to the quorum or voting requirements or the waiver of
certain covenants relating to your debt securities.
|
Changes Not Requiring Your Approval. There are
certain changes that we may make to your debt securities without
your specific approval and without any vote of the holders of
the debt securities of the same
13
series. Such changes are limited to clarifications and certain
other changes that would not adversely affect the holders of the
outstanding debt securities of such series in any material
respect.
Changes Requiring Majority Approval. Subject
to the provisions of the applicable indenture, any other change
to, or waiver of, any provision of an indenture and the debt
securities issued pursuant thereto would require the following
approval:
|
|
|
|
|
If the change affects only one series of debt securities, it
must be approved by the holders of a majority in principal
amount of the outstanding debt securities of that series.
|
|
|
|
If the change affects more than one series of debt securities
issued under the same indenture, it must be approved by the
holders of a majority in principal amount of the outstanding
debt securities of all series affected by the change, with all
affected series voting together as one class for this purpose.
|
|
|
|
Waiver of our compliance with certain provisions of an indenture
must be approved by the holders of a majority in principal
amount of the outstanding debt securities of all series issued
under such indenture, voting together as one class for this
purpose, in accordance with the terms of such indenture.
|
In each case, the required approval must be given in writing.
Acts by
Holders
Debt securities will not be considered outstanding, and
therefore the Holders of such debt securities will not be
eligible to take action under the indenture, if we have
deposited or set aside in trust money for their payment in full
or their redemption. Holders of debt securities will also not be
eligible to take action under the indenture if we can legally
release ourselves from all payment and other obligations with
respect to such debt securities, as described below under
Defeasance.
We will generally be entitled to set any day as a record date
for the purpose of determining the holders of outstanding debt
securities that are entitled take action under the indenture. If
we set a record date for action to be taken by holders of one or
more series of debt securities, such action may be taken only by
persons shown on the trustees records as holders of the
debt securities of the relevant series on such record date.
Book-entry and other indirect holders should consult their
banks or brokers for information on how their approval or waiver
may be granted or denied if we seek their approval to change or
waive the provisions of an applicable indenture or of their debt
securities.
Defeasance
If specified in the applicable prospectus supplement and subject
to the provisions of the applicable indenture, we may elect
either:
|
|
|
|
|
to be released from some of the covenants in the indenture under
which your debt securities were issued (referred to as
covenant defeasance); or
|
|
|
|
to be discharged from all of our obligations with respect to
your debt securities, except for obligations to register the
transfer or exchange of your debt securities, to replace
mutilated, destroyed, lost or stolen debt securities, to
maintain paying offices or agencies and to hold moneys for
payment in trust (referred to as full defeasance).
|
In the event of covenant defeasance, you would lose the
protection of some of our covenants in the indenture, but would
gain the protection of having money and government securities
set aside in trust to repay your debt securities. If we were to
accomplish covenant defeasance, you could still look to us for
repayment of the debt securities if there were a shortfall in
the trust deposit or the trustee were prevented from making
payment. In fact, if an Event of Default that remained after we
accomplish covenant defeasance occurred (such as our bankruptcy)
and your debt securities became immediately due and payable,
there might be a shortfall in our trust deposit. Depending on
the event causing the default, you might not be able to obtain
payment of the shortfall.
14
If we were to accomplish full defeasance, you would have to rely
solely on the funds or notes or bonds that we deposit in trust
for repayment of your debt securities. You could not look to us
for repayment in the unlikely event of any shortfall in our
trust deposit. Conversely, the trust deposit would most likely
be protected from claims of our lenders and other creditors if
we were to become bankrupt or insolvent.
Subject to the provisions of the applicable indenture, in order
to accomplish covenant or full defeasance with respect to the
debt securities offered:
|
|
|
|
|
We must deposit in trust for the benefit of all holders of the
debt securities of the same series as your debt securities a
combination of money and U.S. government or
U.S. government agency notes or bonds that would generate
enough cash to make interest, principal and any other payments
on such series of debt securities on the various dates when such
payments would be due.
|
|
|
|
No Event of Default or event which with notice or lapse of time
would become an Event of Default, including by reason of the
above deposit of money, notes or bonds, with respect to your
debt securities shall have occurred and be continuing on the
date of such deposit.
|
|
|
|
We must deliver to the trustee of such debt securities a legal
opinion of our counsel stating either that we have received, or
there has been published, a ruling by the Internal Revenue
Service or that there had been a change in the applicable
U.S. federal income tax law, in either case to the effect
that, for U.S. federal income tax purposes, you will not
recognize income, gain or loss as a result of such defeasance
and that such defeasance will not cause you to be taxed on your
debt securities any differently than if such defeasance had not
occurred and we had just repaid your debt securities ourselves
at maturity.
|
|
|
|
We must deliver to the trustee a legal opinion of our counsel to
the effect that the deposit of funds or bonds would not require
registration under the Investment Company Act of 1940, as
amended, or that all necessary registration under the Investment
Company Act of 1940, as amended, had been effected.
|
|
|
|
We must comply with any additional terms of, conditions to or
limitations to covenant or full defeasance, as set forth in the
applicable indenture.
|
|
|
|
We must deliver to the trustee of your debt securities an
officers certificate and a legal opinion of our counsel
stating that all conditions precedent to covenant or full
defeasance, as set forth in the applicable indenture, had been
complied with.
|
Information
Concerning the Trustee
The Trust Indenture Act of 1939 contains limitations on the
rights of the trustee, should it become a creditor of ours, to
obtain payment of claims in some cases or to realize on some
property received by it in respect of those claims, as security
or otherwise. Each trustee is permitted to engage in other
transactions with us and our subsidiaries from time to time,
provided that if the trustee acquires any conflicting interest
the trustee must either redeem or eliminate that conflict upon
the occurrence of an event of default under the indenture.
Wilmington Trust Company is the trustee under our
indenture. In the ordinary course of business we may borrow from
and maintain banking relationships with Wilmington
Trust Company and its affiliates. The trust offices of
Wilmington Trust Company are located at 1100 North Market
Street, Wilmington, Delaware 19890.
Governing
Law
The indentures and the debt securities will be governed by, and
construed in accordance with, the law of the State of New York.
15
WHERE YOU
CAN FIND MORE INFORMATION
We are subject to the information and reporting requirements of
the Exchange Act, as amended, under which we file annual,
quarterly and current reports, proxy statements and other
information with the SEC. You may read and copy this information
at the Public Reference Room of the SEC, at
100 F Street, N.E., Washington, DC 20549. Please call
the SEC at (800) SEC-0330 for further information about the
Public Reference Room. In addition, copies of these reports and
other information may be obtained at prescribed rates from the
Public Reference Section of the Commission, 450 Fifth
Street, N.W., Washington, D.C. 20549.
The SEC also maintains an internet website that contains
reports, proxy statements and other information about issuers
that file electronically with the SEC. The address of that site
is www.sec.gov. We also maintain copies of our recent SEC
reports and other current information regarding ProAssurance at
our website at www.proassurance.com.
Our common shares are listed on the New York Stock Exchange
under the symbol PRA. Our reports, proxy statements
and other information may also be read and copied at the New
York Stock Exchange, 20 Broad Street, New York, NY 10005.
This prospectus is part of a registration statement on
Form S-3
filed by us with the SEC under the Securities Act. As permitted
by the SEC, this prospectus does not contain all the information
in the registration statement filed with the SEC. For a more
complete understanding of this offering, you should refer to the
complete registration statement, including exhibits, on
Form S-3
that may be obtained as described above. Statements contained in
this prospectus or in any prospectus supplement about the
contents of any contract or other document are not necessarily
complete. If we have filed any contract or other document as an
exhibit to the registration statement or any other document
incorporated by reference in the registration statement, you
should read the exhibit for a more complete understanding of the
document or matter involved. Each statement regarding a contract
or other document is qualified in its entirety by reference to
the actual document.
INFORMATION
INCORPORATED BY REFERENCE
We are incorporating by reference into this
prospectus certain information that we file with the SEC, which
means that we are disclosing important information to you by
referring you to those documents. The information incorporated
by reference is deemed to be part of this prospectus, except for
any information superseded by information contained directly in
this prospectus, in any prospectus supplement or prospectus
contained in a post- effective amendment or superseded by
information in subsequent reports filed with the SEC. This
prospectus incorporates by reference the documents set forth
below:
|
|
|
|
|
Our Annual Report on
Form 10-K
for the Year Ended December 31, 2009;
|
|
|
|
Our Quarterly Report on
Form 10-Q
for the Quarter Ended March 31, 2010;
|
|
|
|
Our Current Report on
Form 8-K
filed May 19, 2010; and
|
|
|
|
All documents filed by us under Sections 13(a), 13(c), 14
or 15(d) of the Securities Exchange Act of 1934 on or after the
date of this prospectus and before the termination of this
offering.
|
You may request a copy of these filings, at no cost, by writing
or calling us at the following address or telephone number:
Frank B. ONeil
Senior Vice President of Corporate Communications and Investor
Relations
ProAssurance Corporation
100 Brookwood Place
Birmingham, Alabama 35209
Tel:
(205) 877-4400
E-mail:
foneil@proassurance.com
16
Information contained on our website at www.proassurance.com is
not intended to be incorporated by reference in this prospectus
and you should not consider that information a part of this
prospectus.
LEGAL
MATTERS
Unless otherwise stated in a prospectus supplement, certain
legal matters regarding the common stock, preferred stock and
debt securities will be passed upon for us by Burr &
Forman LLP. As of April 30, 2010, partners of
Burr & Forman LLP owned approximately
6,349 shares of our stock or less than 1% of the
outstanding shares on that date. Underwriters, dealers or
agents, if any, who we will identify in a prospectus supplement
may have their counsel pass upon certain legal matters in
connection with the securities offered by this prospectus.
EXPERTS
The consolidated financial statements of ProAssurance
Corporation appearing in ProAssurance Corporations Annual
Report
(Form 10-K)
for the year ended December 31, 2009 (including schedules
appearing therein), and the effectiveness of ProAssurance
Corporations internal control over financial reporting as
of December 31, 2009, have been audited by
Ernst & Young LLP, independent registered public
accounting firm, as set forth in their reports thereon included
therein, and incorporated herein by reference. Such financial
statements are, and audited financial statements to be included
in subsequently filed documents will be, incorporated herein in
reliance upon the reports of Ernst & Young LLP
pertaining to such financial statements and the effectiveness of
our internal control over financial reporting as of the
respective dates (to the extent covered by consents filed with
the Securities and Exchange Commission) given on the authority
of such firm as experts in accounting and auditing.
17
PART II
INFORMATION
NOT REQUIRED IN PROSPECTUS
|
|
Item 14.
|
Other
Expenses of Issuance and Distribution
|
The expenses in connection with the issuance and distribution of
the securities being registered, other than underwriting
discounts and commissions, are set forth in the following table.
All amounts shown are estimates except the Securities and
Exchange Commission (the SEC) registration fee.
|
|
|
|
|
SEC registration fee
|
|
|
*
|
|
Listing fees
|
|
|
**
|
|
Blue sky fees and expenses
|
|
|
**
|
|
Printing fees and expenses
|
|
|
**
|
|
Legal fees and expenses
|
|
|
**
|
|
Accounting fees and expenses
|
|
|
**
|
|
Trustees fees and expenses
|
|
|
**
|
|
Rating agency fees
|
|
|
**
|
|
Transfer agent and registrar fees
|
|
|
**
|
|
Miscellaneous
|
|
|
**
|
|
|
|
|
|
|
Total
|
|
|
**
|
|
|
|
|
* |
|
To be deferred under Rule 456(b) and calculated in
connection with the offering of securities under this
registration statement under Rule 457(r). |
|
** |
|
Because an indeterminate amount of securities is covered by this
registration statement, the expenses in connection with the
issuance and distribution of the securities are not currently
determinable. |
|
|
Item 15.
|
Indemnification
of Directors and Officers
|
As permitted by Delaware law, the Registrants certificate
of incorporation provides that the directors of the Registrant
will not be held personally liable for a breach of fiduciary
duty as a director, except that a director may be liable for
(1) a breach of the directors duty of loyalty to the
corporation or its stockholders, (2) acts made in bad faith
or which involve intentional misconduct or a knowing violation
of the law, (3) illegal payment of dividends under
Section 174 of the Delaware General Corporation Law; or
(4) for any transaction from which the director derives an
improper personal benefit. The Registrants certificate of
incorporation further provides that if Delaware law is amended
to authorize corporate action further eliminating or limiting
the personal liability of directors, then the liability of a
director of the Registrant shall be eliminated or limited to the
fullest extent permitted by Delaware law, as so amended.
The by-laws of the Registrant provide that the Registrant will
indemnify any person involved in litigation brought by a third
party or by or in the right of the Registrant by reason of the
fact that he or she is or was a director, officer, employee or
agent of the Registrant or is or was serving at the request of
the Registrant as a director, officer, employee or agent of
another entity. The Registrant will only indemnify such a person
if that person acted in good faith and in a manner he or she
reasonably believed to be lawful and in the best interests of
the Registrant, except that the person will not be entitled to
indemnification in an action in which he or she is found to be
liable to the corporation unless the Delaware Court of Chancery
deems indemnification under these circumstances proper.
The Registrant maintains in effect directors and
officers liability insurance which provides coverage
against certain liabilities. The Registrant has entered into
indemnification agreements with each of its directors and
executive officers which requires the Registrant to use
reasonable efforts to maintain such insurance during the term of
the agreement so long as the Board of Directors in the exercise
of its business judgment determines that the cost is not
excessive and is reasonably related to the amount of coverage
and that the coverage provides a reasonable benefit for such
cost. The indemnification agreements require the Registrant to
II-1
indemnify the executive officers and directors to the fullest
extent permitted under Delaware law to the extent not covered by
liability insurance, including advances of expenses in the
defense of claims against the executive officer or director
while acting in such capacity. It is a condition to such
indemnification that the indemnitee acted in good faith and in a
manner that he or she believed to be in or not opposed to the
interest of the Registrant or its stockholders, and with respect
to a criminal action had no reasonable cause to believe his or
her conduct was unlawful. Indemnification is not available from
the Registrant:
|
|
|
|
|
in respect to remuneration that is determined to be in violation
of law;
|
|
|
|
on account of any liability arising from a suit for an
accounting of profits for the purchase and sale of
Registrants common stock pursuant to Section 16(b) of
the Securities Exchange Act of 1934, as amended;
|
|
|
|
on account of conduct that is determined to have been knowingly
fraudulent, deliberately dishonest or willful misconduct;
|
|
|
|
if indemnification is prohibited by the applicable laws of the
State of Delaware;
|
|
|
|
if the indemnitee is found to be liable to the Registrant or its
subsidiaries unless the Delaware Court of Chancery determines
that the indemnitee is fairly and reasonably entitled to
indemnification for expenses that the court deems proper; or
|
|
|
|
if a court should determine that such indemnification is not
lawful.
|
The indemnification agreement requires the indemnitee to
reimburse the Registrant for all reasonable expenses incurred or
advanced in defending any criminal or civil suit or proceedings
against the indemnitee if the Registrant determines that
indemnity is not available.
The exhibits to this registration statement are listed in the
Exhibit Index to this registration statement, which
Exhibit Index is hereby incorporated by reference.
The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration
statement:
(a) To include any prospectus required by
Section 10(a)(3) of the Securities Act of 1933, as amended;
(b) To reflect in the prospectus any facts or events
arising after the effective date of this registration statement
(or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change
in the information set forth in this registration statement.
Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of
prospectus filed with the SEC pursuant to Rule 424(b) if,
in the aggregate, the changes in volume and price represent no
more than a 20% change in the maximum aggregate offering price
set forth in the Calculation of Registration Fee
table in the effective registration statement; and
(c) To include any material information with respect to the
plan of distribution not previously disclosed in this
registration statement or any material change to such
information in this registration statement;
provided, however, that paragraphs (1)(a), (1)(b) and 1(c) do
not apply if the information required to be included in a
post-effective amendment by those paragraphs is contained in
reports filed with or furnished to the SEC by the registrant
pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 that are
II-2
incorporated by reference in this registration statement or is
contained in a form of prospectus filed pursuant to
Rule 424(b) that is part of this registration statement.
(2) That, for the purpose of determining any liability
under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(3) To remove from registration by means of a
post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering.
(4) That, for the purpose of determining liability under
the Securities Act of 1933 to any purchaser:
(a) each prospectus filed by a Registrant pursuant to Rule
424(b)(3) shall be deemed to be part of the registration
statement as of the date the filed prospectus was deemed part of
and included in the registration statement; and
(b) each prospectus required to be filed pursuant to Rule
424(b)(2), (b)(5) or (b)(7) as part of a registration statement
in reliance on Rule 430B relating to an offering made
pursuant to Rule 415(a)(1)(i), (vii) or (x) for the
purpose of providing the information required by
Section 10(a) of the Securities Act of 1933 shall be deemed
to be part of and included in the registration statement as of
the earlier of the date such form of prospectus is first used
after effectiveness or the date of the first contract of sale of
securities in the offering described in the prospectus. As
provided in Rule 430B, for liability purposes of the issuer
and any person that is at that date an underwriter, such date
shall be deemed to be a new effective date of the registration
statement relating to the securities in the registration
statement to which the prospectus relates, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof. Provided, however, that no statement
made in a registration statement or prospectus that is part of
the registration statement or made in a document incorporated or
deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will,
as to a purchaser with a time of contract of sale prior to such
effective date, supersede or modify any statement that was made
in the registration statement or prospectus that was part of the
registration statement or made in any such document immediately
prior to such effective date.
(5) That, for the purpose of determining liability of a
registrant under the Securities Act of 1933 to any purchaser in
the initial distribution of the securities, the undersigned
registrant undertakes that in a primary offering of securities
of an undersigned registrant pursuant to this registration
statement, regardless of the underwriting method used to sell
the securities to the purchaser, if the securities are offered
or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such
securities to such purchaser:
(a) any preliminary prospectus or prospectus of the
undersigned registrant relating to the offering required to be
filed pursuant to Rule 424;
(b) any free writing prospectus relating to the offering
prepared by or on behalf of the undersigned registrant or used
or referred to by the undersigned registrant;
(c) the portion of any other free writing prospectus
relating to the offering containing material information about
the undersigned registrant or its securities provided by or on
behalf of the undersigned registrant; and
(d) any other communication that is an offer in the
offering made by the undersigned registrant to the purchaser.
(6) The undersigned registrant hereby undertakes that, for
purposes of determining any liability under the Securities Act
of 1933, each filing of the registrants annual report
pursuant to Section 13(a) or Section 15(d) of the
Securities Exchange Act of 1934 (and, where applicable, each
filing of an employee
II-3
benefits plans annual report pursuant to
Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(7) Insofar as indemnification for liabilities arising
under the Securities Act of 1933 may be permitted to
directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions described under
Item 15 above, or otherwise, the registrant has been
advised that in the opinion of the SEC such indemnification is
against public policy as expressed in the Securities Act of 1933
and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment
by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the
successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant
will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in
the Securities Act of 1933 and will be governed by the final
adjudication of such issue.
(8) The undersigned registrant hereby undertakes to file an
application for the purpose of determining the eligibility of
the trustee to act under subsection (a) of Section 310
of the Trust Indenture Act in accordance with the rules and
regulations prescribed by the SEC under Section 305(b)(2)
of the Trust Indenture Act.
II-4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on
Form S-3
and has duly caused this registration statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the
city of Birmingham, State of Alabama, on the
21st day
of May, 2010.
PROASSURANCE CORPORATION
|
|
|
|
By:
|
/s/ W.
Stancil Starnes
|
W. Stancil Starnes
Chairman of the Board and
Chief Executive Officer
POWER OF
ATTORNEY
Each person whose signature appears below hereby constitutes and
appoints Frank B. ONeil, Edward L. Rand, Jr. and
Victor T. Adamo, jointly and severally, his or her true and
lawful attorneys-in-fact, each with full power of substitution,
for him or her in any and all capacities, to sign any and all
amendments (including post-effective amendments) to this
registration statement, and to file the same, with all exhibits
thereto and all documents in connection therewith, with the
Securities and Exchange Commission, granting unto said
attorneys-in-fact full power and authority to do and perform
each and every act and thing requisite and necessary to be done
and hereby ratifying and confirming all that each of said
attorneys-in-fact or any of them, or his or their substitute or
substitutes, may lawfully do or cause to be done by virtue
hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons
in the capacities and on the dates indicated:
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ W.
Stancil Starnes
W.
Stancil Starnes
|
|
Chief Executive Officer and Chairman of the Board and Director
|
|
May 21, 2010
|
|
|
|
|
|
/s/ Edward
L. Rand, Jr.
Edward
L. Rand, Jr.
|
|
Chief Financial Officer and Senior Vice President
|
|
May 21, 2010
|
|
|
|
|
|
/s/ Victor
T. Adamo
Victor
T. Adamo
|
|
Director
|
|
May 21, 2010
|
|
|
|
|
|
/s/ Lucian
F. Bloodworth
Lucian
F. Bloodworth
|
|
Director
|
|
May 21, 2010
|
|
|
|
|
|
/s/ Jerry
D. Brant
Jerry
D. Brant
|
|
Director
|
|
May 21, 2010
|
|
|
|
|
|
/s/ Robert
E. Flowers
Robert
E. Flowers
|
|
Director
|
|
May 21, 2010
|
|
|
|
|
|
/s/ William
J. Listwan
William
J. Listwan
|
|
Director
|
|
May 21, 2010
|
II-5
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ John
J. McMahon, Jr..
John
J. McMahon, Jr.
|
|
Director
|
|
May 21, 2010
|
|
|
|
|
|
/s/ Drayton
Nabers, Jr.
Drayton
Nabers, Jr.
|
|
Director
|
|
May 21, 2010
|
|
|
|
|
|
/s/ Ann
F. Putallaz
Ann
F. Putallaz
|
|
Director
|
|
May 21, 2010
|
|
|
|
|
|
/s/ William
H. Woodhams
William
H. Woodhams
|
|
Director
|
|
May 21, 2010
|
|
|
|
|
|
/s/ Wilfred
W. Yeargan, Jr.
Wilfred
W. Yeargan, Jr.
|
|
Director
|
|
May 21, 2010
|
II-6
INDEX TO
EXHIBITS
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
1
|
.1*
|
|
Form of Underwriting Agreement for Common Stock and/or Preferred
Stock of ProAssurance.
|
|
1
|
.2*
|
|
Form of Underwriting Agreement for Debt Securities of
ProAssurance.
|
|
4
|
.1
|
|
Form of Indenture between ProAssurance and Wilmington
Trust Company, as Trustee.
|
|
5
|
.1*
|
|
Opinion of Burr & Forman LLP.
|
|
12
|
.1*
|
|
Statement re: Ratios of Earnings to Fixed Charges.
|
|
23
|
.1
|
|
Consent of Ernst & Young LLP
|
|
23
|
.2*
|
|
Consent of Burr & Forman LLP (included in
Exhibit 5.1).
|
|
24
|
.1
|
|
Powers of Attorney (included on signature page hereof).
|
|
25
|
.1
|
|
Form T-1
Statement of Eligibility of Trustee under Debt Indenture of
ProAssurance.
|
|
|
|
* |
|
To be filed by amendment or as an exhibit to a filing with the
SEC pursuant to the Securities Exchange Act of 1934, as amended,
and incorporated herein by reference. |
II-7